SUMMARY This paper presents the clinical and pathological data obtained from 42 patients with oligodendroglioma diagnosed over a 20 year period at Addenbrooke's Hospital, Cambridge. In all cases the diagnosis was established unequivocally by histological examination. The principal conclusions of this study were: (1) the outcome was not as favourable as anticipated, nine patients dying within 1 year of diagnosis, and only 10 patients surviving 5 years, (2) age at the time of diagnosis was the single most important prognostic factor, patients under 45 years at diagnosis having a significantly greater survival time than older patients, (3) two other factors had a significantly adverse effect on prognosis, namely the presence of a focal neurological deficit at the time of diagnosis and the presence of nuclear pleomorphism in the tumour when examined histologically, (4) although cells containing glial fibrillary acidic protein were demonstrated in almost every tumour, their number and distribution did not appear to influence the prognosis.
Oligodendroglioma is less common than astrocytoma and generally considered to have a better prognosis, but it is also described as unpredictable with poor correlation between histological evidence of malignancy and survival.1 -4 Its degree of prognostic uncertainty merits reassessment of its properties. Hence, the objectives of this study were two-fold, firstly to re-examine the clinical features of oligodendroglioma, and secondly to determine if any factors, clinical, pathological or therapeutic, had a significant influence on survival. The recently developed immunoperoxidase technique for the demonstration of glial fibrillary acidic protein (GFAP) was included in the search for predictive histological features.
Patients and methods
Clinical
Forty-two patients with pure oligodendroglioma were diagnosed and treated at Addenbrooke's Hospital, Cam- bridge, between 1961 
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Oligodendroglioma. an analysis of 42 cases Figure 1 shows the anatomical location of the tumours. The frontal predominance is noteworthy. Twenty-two tumours involved the right cerebral hemisphere, 16 the left and four were midline, involving both cerebral hemispheres. There were no infratentorial tumours in this series. Figure 2 endeavours to show the relationship between the nature of the first symptom and tumour site. However, the nature of the first symptom did not show good correlation with the intracerebral location with the possible exception of tumours situated in the fronto-temporal or temporal region, of which seven Calcification of the tumour was diagnosed preoperatively in 21 (50%) patients, in 18 of 36 who had skull radiographs and in 12 of 24 who had a CT scan, (some patients had both investigations).
The surgical treatment was biopsy only in 10 cases, subtotal removal in 18 and macroscopic removal in 14 patients. Thirty-eight patients had a full course of radiotherapy immediately post-operatively, consisting of between 4,000 and 4,950 rad administered in 15 to 20 fractions. Three patients declined very rapidly after their surgical treatment and were never able to undergo a full course of radiotherapy. One patient did not receive radiotherapy after the initial surgery, but it was given with benefit 18 months later for tumour recurrence. Thus in this series there is only one patient who has survived for several years who did not receive early radiotherapy. The majority of patients in this survey received practically the same management, a major surgical resection followed by radiotherapy. Oligodendroglioma: an analysis of 42 cases
At the time of data collection in July 1984 the outcome of treatment was known in 41 of the 42 patients. The one remaining patient was lost to follow-up 4 years after operation. The median survival time was 44 months and only 14 patients were known to be alive in July 1984. Ten patients had survived for 5 years or more, the longest survivor remaining alive and well 17 years after treatment. Nine of the patients had died within a year of treatment, one as a result of pulmonary embolism, but as a direct result of the tumour in the other eight.
Histologicalfindings
Re-assessment of the original haematoxylin and eosin stained sections in 1984 confirmed the original diagnosis of oligodendroglioma. In two cases only, the possibility of an astrocytomatous component was queried at this stage, but because of a definite preponderance of distinctly oligodendrogliomatous tissue these cases were retained. Histological grading, (as set out in 6. In patterns 1 and 2 the large cells with long pro- 4 Wilkinson, Anderson, Holmes cesses were interpreted as reactive astrocytes, because they appeared to be a completely different population from the small rounded tumour cells with no transitional forms and also because identical patterns can be seen in non-glial neoplasms, such as malignant cerebral lymphoma. The astrocytic network pattern was particularly characteristic of the grade I tumour, present in all but 1/11 tumours. However the finding of reactive astrocytes within the tumour was not Other factors which showed trends by this method of analysis, but which did not achieve statistical significance, include the duration of symptoms prior to diagnosis, radiological evidence of calcification, mitotic activity in the tumour and its overall histological grade. Patients with a long history, with a calcified tumour, with low mitotic rates and low histogical grade fared better, but the trends in the survival curves did not achieve statistical significance for these factors.
Trends for other clinical, treatment and histological characteristics were sought but not found. Hence, there was no demonstrable correlation between survival time and the following clinical features; sex, nature of the first symptom, occurrence of epilepsy, raised intracranial pressure or location of the tumour. The different surgical procedures did not produce any significant differences in survival time and there was equally negative correlation with the following histological features; necrosis, vascular endothelial cell proliferation, clear cell change and the various patterns of GFAP containing cells in the tumour.
Discussion
Analysis of the comprehensive data collected from these patients has clarified the common clinical features of oligodendrogliomas and has revealed certain clinical and pathological factors of prognostic significance. Following a brief preliminary communication,'4 the results are now discussed in detail.
In the first category this series has emphasised that oligodendrogliomas are tumours of the cerebral hemispheres in adults. The fact that over 20 years in a regional neurosurgical centre only one oligodendroglioma has been diagnosed in childhood has confirmed their rarity in this age group. Likewise, subtentorial oligodendrogliomas are unusual and there were none in this group. A frequent frontal location has been confirmed. A long preceding history of epilepsy and radiological tumour calcification are also common. It must be emphasised however that half the patients in this study gave a history of less than a year, half the patients did not present with epilepsy as their initial symptom, and half the patients showed no calcification of their tumour on skull radiographs or CT scan. Clearly diagnostic thoughts of oligodendroWilkinson, Anderson, Holmes glioma cannot be confined to patients with a calcified lesion presenting with a long history of epilepsy.
In the second category, the first observation must be the rather poor overall prognosis for patients with oligodendroglioma. Whilst comparing well with the prognosis for patients with grade 3 and 4 astrocytomas,' 5 the outlook for patients with oligodendroglioma in this series was only fair, (9/42 patients, 21%, dying within 1 year and only 10/42 patients, 24%, surviving 5 years from the time of diagnosis and treatment). This outcome is similar to several reports on survival in the literature, but not as satisfactory as the figures produced by Smith et al, 48% 5 year survival'6 and by Chin et al, 60% 5 year survival. 3 Previous workers have had difficulty in establishing any clinical factors which have correlated reliably with prognosis. The unpredictability of oligodendroglioma is a feature of many reports. In this study, age at the time of diagnosis has been shown to be an overriding and statistically significant factor. In this fairly small series it is not possible to determine whether the adverse effect of age is solely due to the inability of older patients to withstand the presence of a brain tumour and the effects of anaesthesia and major surgery, or whether there is a genuine difference in the biological behaviour of the tumours. Even if it is not the only factor, it seems likely that comparatively poorer general health must to some extent be responsible for the more rapid demise of the older patients. If so, even more rigorous attention to pre-operative and post-operative care may increase the survival in this group. In this series, eight patients from the older group died within the first few postoperative weeks, (one from pulmonary embolus, but the rest from the direct effects of their brain tumour). All of the younger patients survived the postoperative period and the earliest death in this group was at 1 year. The series is too small to prove a significant biological difference in the tumours of older patients, but it is of interest that the majority of grade I tumours, eight out of I1, were identified in the younger patients.
The 
